It is very unlikely that the [Communist Party] will allow foreign pharmas to make a decent profit in China.
Then why does every Big Pharma have a major presence in China? Actavis (who recently pulled out) is the exception, not the rule.
Tidbit apropos to this discussion: On a CC a few years ago (when Plavix was still on-patent in the EU), SNY’s COO revealed that Plavix had a higher price and a higher profit margin in China than it did in France (#msg-48744056).
#msg-69250780 is a good background read on Lipitor and Plavix sales as branded generics.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”